Clinical utility of transperineal template-guided mapping biopsy of the prostate after negative magnetic resonance imaging-guided transrectal biopsy. En savoir plus sur Clinical utility of transperineal template-guided mapping biopsy of the prostate after negative magnetic resonance imaging-guided transrectal biopsy.
Evolution from laparoscopic to robotic nephron sparing surgery: a high-volume laparoscopic center experience on achieving 'trifecta' outcomes. En savoir plus sur Evolution from laparoscopic to robotic nephron sparing surgery: a high-volume laparoscopic center experience on achieving 'trifecta' outcomes.
Robotics in urological surgery: Evolution, current status and future perspectives. En savoir plus sur Robotics in urological surgery: Evolution, current status and future perspectives.
Transperineal template-guided mapping biopsy of the prostate. En savoir plus sur Transperineal template-guided mapping biopsy of the prostate.
Prostate histoscanning true targeting guided prostate biopsy: initial Clinique inical experience. En savoir plus sur Prostate histoscanning true targeting guided prostate biopsy: initial Clinique inical experience.
T-helper 1 immunoreaction influences survival in musClinique e-invasive bladder cancer: proof of concept. En savoir plus sur T-helper 1 immunoreaction influences survival in musClinique e-invasive bladder cancer: proof of concept.
How to diagnose and treat focal therapy failure and recurrence? En savoir plus sur How to diagnose and treat focal therapy failure and recurrence?
Positive surgical margins after minimally invasive radical prostatectomy in patients with pT2 and pT3a disease could be considered pathological upstaging. En savoir plus sur Positive surgical margins after minimally invasive radical prostatectomy in patients with pT2 and pT3a disease could be considered pathological upstaging.
Oncologic outcomes after minimally invasive radical prostatectomy in patients with seminal vesiClinique e invasion (pT3b) without adjuvant therapy. En savoir plus sur Oncologic outcomes after minimally invasive radical prostatectomy in patients with seminal vesiClinique e invasion (pT3b) without adjuvant therapy.